EIP
FLGT icon

Easterly Investment Partners’s Fulgent Genetics FLGT Stock Holding History

Easterly Investment Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,619
Closed -$669K – 218
2025
Q3 		$669K Buy
+29,619
New +$610K 0.05% 167
2025
Q2 		– Sell
-11,729
Closed -$198K – 198
2025
Q1 		$198K Buy
+11,729
New +$200K 0.02% 183
2024
Q4 		– Sell
-9,558
Closed -$208K – 204
2024
Q3 		$208K Buy
+9,558
New +$214K 0.02% 196

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Easterly Investment Partners's FLGT Position: Q4 2025 in Review

Easterly Investment Partners sold out of Fulgent Genetics (FLGT) in Q4 2025, closing a stake of 29,619 shares — an estimated $669K sold.

Easterly Investment Partners first reported a position in FLGT in Q3 2024 and held it in 3 quarters. The position peaked at $669K in Q3 2025. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • Easterly Investment Partners reported no remaining Fulgent Genetics position as of Q4 2025 after selling out during the quarter.
  • Easterly Investment Partners sold 29,619 Fulgent Genetics shares in Q4 2025, an estimated $669K.
  • Easterly Investment Partners first reported a position in Fulgent Genetics in Q3 2024 and held it in 3 quarters.
  • Easterly Investment Partners's Fulgent Genetics position peaked at $669K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Easterly Investment Partners's 13F filing for Q4 2025, filed 10 Feb 2026.